Skip to main content
Log in

Teratologic studies on the Himalayan rabbit: new aspects of thalidomide-induced teratogenesis

  • Original Investigations
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The aim of our study was to determine the period of maximum sensitivity for the induction of characteristic malformations with thalidomide (TH) in Himalayan rabbits. TH was administered orally in different doses (50, 100, 150 and 200 mg/kg) four times at 24-h intervals starting at 192 h of gestation. The malformations affected various organs: renal defects (dysplasia) and limb anomalies (dysmelia) — which had never occurred spontaneously in this strain — appeared as dose-dependent effects of the drug. By administering single doses of TH (200 and 300 mg/kg body wt) between hours 192 and 264 of gestation, we discovered the different periods of maximum sensitivity for induction of renal dysplasia (clearly prior to the 220th h of gestation) and dysmelia (between hours 230 and 240 of gestation). The types of limb malformations that we observed in the rabbit were identical to those produced in man following the intake of TH. Three doses of TH (300 mg/kg each) given between hours 222 and 228 of gestation produced characteristic limb malformations in 9 of 11 litters treated. These results make it possible to conduct in vivo experiments on a readily available laboratory animal with minor drug exposure of the gravid dam and under avoidance of toxic side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Blake DA, Martz F, Failinger III C, Gery-Martz AM (1978) Arene oxide-mediated chemoteratogenesis. In: Jones PW, Freudenthal RI (eds) Carcinogenesis Vol 3: Polynuclear aromatic hydrocarbons. Raven Press, New York, pp 401–411

    Google Scholar 

  • Braun AG, Weinreb SL (1984) Teratogen metabolism: Activationof thalidomide and thalidomide analogues to products that inhibit the attachment of cells to concanavalin A coated plastic surfaces. Biochem Pharmacol 33: 1471–1477

    Google Scholar 

  • Braun AG, Weinreb SL (1985) Teratogen metabolism: Spontaneous decay products of thalidomide and thalidomide analogues are not bioactivated by liver microsomes. Teratogen Carcinogen Mutagen 5: 149–158

    Google Scholar 

  • Dekker A, Mehrizi A (1964) The use of thalidomide as a teratogenic agent in rabbits. Bull Hopkins Hosp 115: 223–230

    Google Scholar 

  • Fabro S, Smith RL (1966) The teratogenic activity of thalidomide in the rabbit. J Pathol Bacteriol 91: 511–519

    Google Scholar 

  • Frankus E (1983) Teratogene und nicht-teratogene Analoga des Thalidomids. Dtsch Apoth Ztg 123: 391

    Google Scholar 

  • Gordon GB, Spielberg SP, Blake DA, Balasubramanian V (1981) Thalidomide teratogenesis: Evidence for a toxic arene oxide metabolite. Proc Natl Acad Sci USA 78: 2545–2548

    Google Scholar 

  • Hartman HA (1974) The fetus in experimental teratology. In: Weisbroth SH, Flatt RE, Kraus AL (eds) The biology of the laboratory rabbit. Academic Press, New York-London, pp 91–153

    Google Scholar 

  • Helm F (1966) Tierexperimentelle Untersuchungen und Dysmeliesyndrom. Arzneim Forsch 16: 1232–1244

    Google Scholar 

  • Helm F, Becker R, Flohé L, Frankus E, Graudums I, Hendrickx A, Scott W (1980) Lack of teratogenicity of supidimide. 7th Int Sympos Med Chem, Torremolinos (Spain), Poster 180

  • Helm F-C, Frankus E, Friderichs E, Graudums I, Flohé L (1981) Comparative teratological investigation of compounds structurally and pharmacologically related to thalidomide. Arzneim Forsch 31: 941–949

    Google Scholar 

  • Hendrickx AG, Helm F-C (1980) Nonteratogenicity of a structural analog of thalidomide in pregnant baboons (Papio cynocephalus). Teratology 22: 179–182

    Google Scholar 

  • Ingalls TH, Curley FJ, Zappasodi P (1964) Thalidomide embryopathy in hybrid rabbits. N Engl J Med 271: 441–444

    Google Scholar 

  • Jonckheere AR (1954) A distribution-free k-sample test against ordered alternatives. Biometrika 41: 133–145

    Google Scholar 

  • Keller GR, Blake DA (1971) Comparative studies on the absorption of 3H-thalidomide in rabbits and rats. Teratology 4: 75–85

    Google Scholar 

  • Koch H (1981) Die Arenoxid-Hypothese der Thalidomid-Wir-kung. Überlegungen zum molekularen Wirkungsmechanismus des “klassischen” Teratogens. Sci Pharm 49: 67–99

    Google Scholar 

  • Koch H, Kotlan J (1966) Thalidomid-Analoga. Monatsh Chem 97: 1648–1659

    Google Scholar 

  • Lehmann H, Niggeschulze A (1971) The teratologic effects of thalidomide in Himalayan rabbits. Toxicol Appl Pharmacol 18: 208–219

    Google Scholar 

  • Mann HB, Whitney DR (1947) On a test of whether one of two random variables is stochastically larger than the other. Ann Math Statist 18: 50–60

    Google Scholar 

  • Martz F, Failinger III C, Blake DA (1977) Phenytoin teratogenesis: Correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue. J Pharmacol Exp Ther 203: 231–239

    Google Scholar 

  • Mikami T, Matsubara Y, Suzuki Y, Chiba T (1981) Teratogenic effects of thalidomide in rabbits: (2) Craniofacial malformations by thalidomide in JW-NIBS rabbits. Teratology 24 (1): 20A

  • Neubert D, Dillmann I (1980) On the problem of phase specificity in limb teratogenesis. In: Merker H-J, Nau H, Neubert D (ededs) Teratology of the limbs. de Gruyter, Berlin — New York, pp 243–252

    Google Scholar 

  • Nothdurft H, Sterz H (1977) Routine radiography of the skeletons of 31-day-old rabbit fetuses. In: Neubert D, Merker H-J, Kwasigroch TE (eds) Methods in prenatal toxicology. Thieme, Stuttgart, pp 155–164

    Google Scholar 

  • Schumacher H, Blake DA, Gurian JM, Gillette JR (1968) A comparison of the teratogenic activity of thalidomide in rabbits and rats. J Pharmacol Exp Ther 160: 189–200

    Google Scholar 

  • Schützenberger WG, Kolassa N, Wiener H, Kraupp O, Tuisl E (1979) Pharmacological properties of taglutimide, a new sedative-hypnotic drug. Arzneim Forsch 29: 1146–1150

    Google Scholar 

  • Scott WJ, Wilson JG, Helm F-C (1980) A metabolite of a structural analog of thalidomide lacks teratogenic effect in pregnant rhesus monkeys. Teratology 22: 183–185

    Google Scholar 

  • Sterz H (1977) Routine examination of rat and rabbit fetuses for malformation of internal organs. Combination of Barrow's and Wilson's methods. In: Neubert D, Merker H-J, Kwasigroch TE (eds) Methods in prenatal toxicology. Thieme, Stuttgart, pp 113–122

    Google Scholar 

  • Stockinger L, Koch H (1969) Teratologische Untersuchung einer neuen, dem Thalidomid strukturell nahestehenden sedativhypnotisch wirksamen Verbindung (K-2004). Arzneim Forsch 19: 167–169

    Google Scholar 

  • Warkany J (1971) Sensitive or critical periods in treatogenesis:Uses and abuses of embryologic timetables. In: Warkany J (ed) Congenital malformations. Year Book Medical Publishers, Chicago, pp 49–52

    Google Scholar 

  • Willert HG, Henkel HL (1969) Klinik und Pathologie der Dysmelie. Springer, Berlin — Heidelberg — New York

    Google Scholar 

  • Wilson JG (1954) Differentiation and the reaction of rat embryos to radiation. J Cell Comp Physiol 43 (Suppl 1): 11–37

    Google Scholar 

  • Wilson JG (1973) Principles of teratology. In: Wilson JG (ed) Environment and birth defects. Academic Press, New York — London, pp 11–34

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sterz, H., Nothdurft, H., Lexa, P. et al. Teratologic studies on the Himalayan rabbit: new aspects of thalidomide-induced teratogenesis. Arch Toxicol 60, 376–381 (1987). https://doi.org/10.1007/BF00295758

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00295758

Key words

Navigation